(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid, 97%, 250mg

Bis(methylthio)methane>98.0%(GC)25mL

Ethyl 2-amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylate, 95.0%, 100g

ethyl 5-amino-3-bromo-1H-pyrazole-4-carboxylate, 97%, 250mg

Tert-butyl (3S,5S)-3-hydroxy-1-oxa-7-azaspiro[4.5]Decane-7-carboxylate, 98%, 250mg

bScope BS.1153-PLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

(2Z)-2-benzylidene-1,3-dioxoindane-5-carboxylic acid, 95.0%, 5g

Potassium metavanadate, min. 97.5%, pure, 50 g, plastic packaging.

(+)-5,6-O-Isopropylidene-L-ascorbic Acid>98.0%(HPLC)(T)25g

(5E)-5-(2-isobutoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

Piperazine, 1-(2-methoxyphenyl)-4-(trichloroacetyl)-, 98%, 1g

tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 250mg

(4-Methylbenzyl)hydrazine hydrochloride, 95.0%, 5g